DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
Public ClinicalTrials.gov record NCT07635563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Randomized, Double-Blind, Multidose Crossover Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnea
Study identification
- NCT ID
- NCT07635563
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Incannex Healthcare Ltd
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide Drug
- IHL-42X: 5 mg dronabinol + 125 mg acetazolamide Drug
- IHL-42X: 7.5 mg dronabinol + 125 mg acetazolamide Drug
- IHL-42X: 2.5 mg dronabinol + 250 mg acetazolamide Drug
- IHL-42X: 5 mg dronabinol + 250 mg acetazolamide Drug
- IHL-42X: 7.5 mg dronabinol + 250 mg acetazolamide Drug
- IHL-42X: 2.5 mg dronabinol + 375 mg acetazolamide Drug
- IHL-42X: 5 mg dronabinol + 375 mg acetazolamide Drug
- IHL-42X: 7.5 mg dronabinol + 375 mg acetazolamide Drug
- Placebo: Negative control Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2026
- Primary completion
- Mar 31, 2027
- Completion
- Apr 30, 2027
- Last update posted
- Jun 8, 2026
2026 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Exalt Clinical Research | Chula Vista | California | 91910 | — |
| Teradan Clinical Trials LLC | Brandon | Florida | 33511 | — |
| CNS Healthcare - Jacksonville | Jacksonville | Florida | 32256 | — |
| CNS Healthcare Orlando | Orlando | Florida | 32801 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Conquest Research/Neurotrials | Winter Park | Florida | 32789 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| Velocity Clinical Research, Rockville | Rockville | Maryland | 20854 | — |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | — |
| Intrepid Research | Cincinnati | Ohio | 45245 | — |
| Velocity Clinical Research, Anderson | Anderson | South Carolina | 29621 | — |
| CNS Healthcare - Memphis | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials of Dallas | Dallas | Texas | 75251 | — |
| Sleep Therapy & Research Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07635563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07635563 live on ClinicalTrials.gov.